Does sunscreen prevent skin cancer? Facts, risks and practical choices.

The conclusion in one minute

Sunscreen protects against sunburn and can help prevent some skin cancers. No single percentage reduction applies to everyone's overall skin cancer risk.

• Evidence varies: clearest for squamous cell carcinoma (SCC), promising but uncertain for melanoma; the main trial found no convincing reduction in basal cell carcinoma.
• SPF is not a percentage reduction in cancer. SPF 30 or 50 describes sunburn protection under test conditions.
• Protect uncovered skin from UV index 3: prioritise shade and clothing, then sunscreen. Short exposures generally offer less absolute benefit from protection than prolonged exposure.
• Price is not decisive. Choose reliable sunscreen with SPF 30 or higher and UVA protection; apply generously and reapply during exposure.

Count tumours and people separately: fewer SCC tumours does not mean the same percentage fewer people with any skin cancer. Figures follow below.[3][4][5]

General information, not personal advice. Previous skin cancer, immunosuppression, light sensitivity or other specific risks may require stricter protection; consult a doctor.

1. What sunscreen does and does not do

UV radiation from the sun can damage the DNA in skin cells. If this damage accumulates, cancer can develop. UVB is the main cause of sunburn; UVA contributes to skin ageing, among other effects. Both can contribute to skin cancer. Sunscreen filters absorb UV radiation or reflect some of it, so that less radiation reaches the skin.[1][10]

What does SPF 30 or 50 mean?

SPF compares the amount of UV radiation needed to cause sunburn under test conditions with and without the product. The number mainly tells you about UVB. For protection against both types, choose a broad-spectrum product; in the Netherlands, one way to identify adequate UVA protection is the UVA symbol inside a circle on the packaging.[7][10]

In simplified terms, correctly applied SPF 30 lets through approximately 1/30 of the UV dose responsible for sunburn, and SPF 50 approximately 1/50. This is often summarised as around 97% and 98% protection. The difference seems small, but the remaining dose falls from approximately 3.3% to 2%. These are not percentages of reduction in skin cancer, nor a measure of protection against all UVA radiation.

SPF is not a stopwatch either: SPF 50 does not mean you can safely stay in the sun fifty times as long. The UV index, applying too thin a layer, missed areas, sweat, water and friction all change the actual protection. UV damage can occur even without visible sunburn.[7][9]

2. How much less skin cancer: the figures without the sales pitch

“Skin cancer” is not a single disease. Squamous cell carcinoma (SCC) can spread to other parts of the body. Basal cell carcinoma (BCC) usually grows locally, but can cause extensive tissue damage. Melanoma develops from pigment cells and can spread dangerously. An effect on one type cannot automatically be attributed to all types combined.[1]

The main trial: Nambour, Australia

In 1992, 1,621 adults aged 25–75 were randomly allocated to two groups: 812 were advised to apply a broad-spectrum product of approximately SPF 16 daily, while 809 used sunscreen at their own discretion. The daily-use group applied it to exposed areas of the head/face, neck, arms and hands. The active trial lasted approximately 4.5 years; researchers then followed the groups for longer.[3][4][6]

This was therefore not “sunscreen versus never using sunscreen”. People in the control group used it too. Not all participants followed their instructions perfectly. The study tested a practical programme of regular sunscreen use, not flawless lifelong use of today's SPF 50.

The uncertainty ranges are the 95% confidence intervals, converted to percentage changes. Statistical significance is not a magical dividing line between “true” and “false”; the width of the interval and the small number of cases are at least as important. The invasive melanoma row is a subset of all melanomas and must not be added to the total.[3][4][5]

What does that mean in actual numbers?

Below, the numbers of affected people have been divided by the original group sizes. This gives an accessible picture of the absolute differences, alongside the relative percentages above.

How to read this: these calculations use the published counts; differences were calculated before rounding. These are descriptive, crude proportions, not adjusted for deaths or differences in the length of follow-up. The published relative measures do account for observation time. For SCC, this concerns a new cancer during this period, not necessarily a person's first-ever skin cancer. Melanoma follow-up covered approximately fourteen years from randomisation; participants were not assigned the same treatment under controlled conditions for fourteen years.[4][5]

For melanoma, the crude comparison works out at approximately 1.35% versus 2.72%: a difference of approximately 1.36 percentage points, not 50 percentage points. That reduction remains uncertain, as the table shows. These figures are also not a personal prediction for someone who occasionally goes for a walk in the Netherlands.

Why was Cochrane's conclusion so cautious?

The 2016 Cochrane review found only one suitable randomised trial addressing prevention of BCC and SCC in the general population: Nambour. During the original trial, 22 of the 812 people in the daily-use group developed an SCC, versus 25 of the 809 in the other group. For BCC, the figures were 65 versus 63. These differences in the number of affected people were not statistically significant. Cochrane rated the certainty of the evidence for these outcomes as low.[6]

That does not contradict the lower number of SCC tumours: one person can develop several tumours. The more favourable results for the number of people developing SCC emerged with longer follow-up. Such follow-up is useful, but it is not a continuation of a fully controlled sunscreen trial. Both “Cochrane proves it does not work” and “40% less skin cancer for everyone has been proven” are therefore too categorical.

Why do sunscreen users actually have more skin cancer in some studies?

Because users and non-users are often not comparable. People with fair, easily burnt skin or high sun exposure are precisely those who use sunscreen more often. Without proper adjustment, this can make the product look “suspicious”. A systematic review describes how adjusting for skin characteristics and sun exposure shifts the estimates towards protection. This does not make such observations worthless, but it does mean they cannot support a simple conclusion that sunscreen causes cancer.[18]

3. When is sunscreen useful?

You do not need to cover your whole body in sunscreen for every shopping trip. But sunscreen is not just for people lying on the beach either. What matters is the amount of UV reaching unprotected skin: how strong the radiation is, how long you are exposed, which areas of skin are uncovered and how sensitive that skin is.

The most important starting point is the UV index, not the temperature. It is often shown in weather apps. If possible, check the value for the time you will be outside, not just the day's maximum. UV exposure can still be high on a cool or cloudy day. You cannot feel UV: heat is something different.[1][2][16]

What counts as “prolonged”? There is no fixed threshold in minutes.

Fifteen minutes in strong midday sunshine can deliver more UV than a longer walk at a low UV index. With other conditions unchanged, twice as much time means approximately twice the UV dose. Several short periods also add up: walking there, walking back, waiting outside and sitting on the balcony later.

A rule such as “you never need sunscreen for less than 20 minutes” is therefore not scientifically defensible. Nor do you have a personal allowance of “safe unprotected minutes”. The difference in later cancer risk from a single short shopping trip cannot be reliably quantified. A shorter exposure does, however, generally mean a smaller absolute benefit from protection than many hours of exposure.

These are practical applications of advice from WHO, KWF, KNMI and Cancer Council, not findings from separate cancer trials on shopping trips or walks. There is no sharp biological boundary between a UV index of 2.9 and 3.0, or between 19 and 20 minutes.[1][2][8][16][17]

Who needs extra caution?

Particularly people who burn easily, children, people with many moles or a history of skin cancer, and people with weakened immune systems or taking medicines that make the skin sensitive to light. Personalised advice may then differ from the table. KWF advises keeping babies under 1 year out of direct sunlight: shade and clothing are the foundation, rather than relying on sunscreen alone.[1][8]

What about dark skin?

On average, dark skin burns less easily and carries a lower risk of UV-related skin cancer. But the risk is not zero. Avoid sunburn and match protection to exposure. The precise cancer-prevention percentages from research in predominantly fair-skinned Australians cannot simply be applied to dark skin.[1]

4. What should you buy, and how do you know you are applying enough?

Seek shade, cover up, apply sunscreen is not a sales slogan for more cream, but a useful order of priorities. Shade and suitable clothing reduce exposure without requiring you to constantly maintain an even layer of product. Even in the shade, UV can still reach your skin through reflection and scattering.[1][8]

A straightforward choice

• Check both types of protection: SPF mainly for UVB, plus UVA inside a circle. The UVA symbol means that UVA protection is at least one third of the stated SPF.
• Choose a reputable seller and check the packaging and shelf life. Read the label, including instructions and warnings. A recent independent product test can help; no brand name replaces quality control.
• Take enough with you. A small, expensive tube of facial sunscreen is impractical for a family at the beach. An affordable larger bottle makes it easier to apply generously.
• Let your skin help guide your choice. If you experience stinging or a rash, a different product may suit you better. “Fragrance-free” or “sensitive skin” does not guarantee that nobody will react to it.

No specific brand is named as a winner here without an up-to-date, independent comparison of the exact products. The criteria above are more concrete and better supported than a general ranking of expensive and inexpensive brands.[9][10][15]

How to make “enough” measurable

You cannot feel the SPF or judge it by how shiny your skin looks. Nor does “I did not get sunburnt” prove that you achieved the stated protection. Use an amount as a guide instead:

1. Apply generously and evenly. The laboratory test uses approximately 2 milligrams per square centimetre of skin. As a practical guideline, KWF suggests approximately seven teaspoons for one application to a largely uncovered adult body: one for the face and neck, two for the arms and shoulders, two for the chest/abdomen/back and two for the legs and feet. The amount needed depends on body size and how much skin is exposed.
2. If needed, measure it once with a 5 ml measuring spoon. Seven of these spoonfuls is approximately 35 ml. A 100 ml bottle therefore contains only about three such full-body applications, not enough for an entire beach holiday. This is a calculation for an adult body, not a fixed dose for every child.
3. Apply only where clothing does not provide protection. You do not need to use 35 ml for a walk in long sleeves and trousers. The face, ears, neck and backs of the hands often remain exposed, though. Cancer Council uses approximately one teaspoon as a guideline for the face, neck and ears combined; add more for the hands if needed.
4. Apply systematically so that you do not miss areas. Work through the body areas one at a time. You can divide the total measured amount into two consecutive applications; this makes it easier to cover any missed areas. Two very thin layers do not automatically add up to enough product. The “two-finger rule” is also only an estimate: the amount varies with the nozzle, finger length and how thickly you squeeze out the lines.
5. Start before exposure. KWF recommends applying approximately half an hour before going outside. Also follow the product instructions. Do not forget the ears, back of the neck, feet, hands and a bald scalp; a hat helps with the latter.
6. Reapply approximately every two hours during exposure. Also reapply after swimming, heavy sweating or towel-drying, even with a “water-resistant” product. Product can be removed or become unevenly distributed.
7. Do not use it to spend longer baking in the sun. Seek shade, especially around midday, and wear clothing and a hat. A tan is a response to UV damage, not proof of health.
8. Pay attention to shelf life and storage. Check the expiry date or the open-jar symbol. Do not store the product for long periods in a hot car or in direct sunlight. Shelf life after opening varies by product; twelve months is common, not a universal guarantee.

Amounts are practical guidelines, not a home measurement of your actual SPF. They are based on KWF, Cancer Council, Cancer Research UK and the standard application thickness in sunscreen tests. Rubbing your skin dry with a towel or swimming can therefore make reapplication necessary before two hours have passed.[8][9][11][17]

Spray, cream or lotion? A spray can protect if enough actually reaches the skin, but this is easier to get wrong because of airborne spray and missed areas. A lotion or cream is often easier to apply in the right amount. Avoid inhaling spray and do not spray directly onto the face.[8][10]

5. Are concerns about ingredients and vitamin D nonsense?

No, not every concern is nonsense. But a real uncertainty is not proof that sunscreen does more harm than good. The questions to ask each time are: which substance, what amount, which route of exposure and what actual demonstrated harm to health?

It is therefore too simplistic to say “it is allowed to be sold, so there can never be anything wrong with it”. Unwanted reactions, inadequate protection or contamination can occur. Conversely, “this substance has a hazardous property” does not mean that every amount applied to the skin carries the same health risk. A substance's hazard and the risk at a particular level of exposure are different things.

UV filters in the blood: demonstrated. Cancer caused by them: not demonstrated.

A 2020 randomised FDA study in 48 adults showed that six UV filters studied could pass through the skin into the blood. Sunscreen was applied generously: to 75% of the body surface, initially once and then several times a day. All six exceeded an FDA threshold above which additional safety data are needed; this happened after just one application.[11]

That threshold was not a level above which harm has been proven to occur. The study measured absorption, not the development of cancer, infertility or other long-term diseases. “It gets into your blood, so it causes cancer” is therefore an incorrect conclusion. “There is nothing left to investigate” would also be unjustified. The researchers saw no reason to stop using sunscreen on this basis.

Endocrine disruption and “natural” filters

Some filters show hormonal effects in animal or laboratory studies. That deserves assessment, but does not automatically prove that normal use causes disease in humans. In the EU, only authorised filters may be used, within permitted concentrations; safety assessments can lead to revised limits. There is no complete certainty about the long-term effects of every ingredient.[10]

Specific names involved in these discussions include homosalate (labelled Homosalate), oxybenzone (Benzophenone-3) and octocrylene (Octocrylene). Their use is restricted in Europe; that does not mean normal authorised use has been proven to cause cancer in humans. For oxybenzone, for example, Dutch public information on substances explicitly states that evidence of it causing cancer is lacking.[19]

“Mineral”, “natural” and “chemical” are not, in themselves, a useful ranking of safety or effectiveness. Zinc oxide and titanium dioxide are chemicals too. Anyone who prefers to avoid certain organic filters can choose a suitable mineral product, but must still pay attention to tested SPF, UVA protection and correct use. Moreover, safety when applied to the skin is not the same as safety when fine particles are inhaled.[10]

This distinction is relevant to titanium dioxide, for example: concerns about swallowing it or inhaling fine particles cannot simply be translated into the same risks from a cream on the skin. The word nano on a label therefore does not automatically mean “this causes cancer”. A lotion or cream avoids the unnecessary inhalation that can occur with a fine spray.[19]

Benzene contamination: a real quality problem

Sunscreen sprays have indeed been recalled because of contamination with benzene, a carcinogenic substance. That is a good reason for testing, recalls and not using affected products. It is not evidence that benzene is a necessary ingredient in sunscreen, or that all sunscreen causes cancer. Even after these recalls, the FDA advises continuing to use suitable, non-recalled sunscreen as part of sun protection.[12]

Irritation and allergy

A product can sting, irritate the eyes or cause contact allergy. These are real drawbacks. If you have symptoms, choose another suitable product, for example one without the fragrance or filter responsible, and seek advice if reactions persist. A reaction to one cream does not mean UV protection is impossible; clothing and shade remain useful.[10]

6. Where does marketing come in?

A higher price does not mean a higher protection factor

Luxury packaging, a “dermatological” image, added plant extracts or an influencer brand do not prove better cancer prevention. Cancer Research UK explicitly states that brand is not the deciding factor: choose sufficient SPF and UVA protection and a product you are willing to use generously and regularly. An affordable cream that works well and feels pleasant to apply can be a better choice than an expensive one you use too sparingly.[9]

Labels deserve scrutiny, not blind trust

In 2023, the NVWA examined 54 sunscreen products. Three products had an SPF lower than stated on the label, including when tested using the standard method on human volunteers; enforcement action was taken against these products. For other products, a newer laboratory method gave lower results than the usual method. The latter is a genuine debate about measurement methods, not automatic proof that all those manufacturers committed fraud.[15]

These findings show why independent testing and oversight are needed. They do not justify the conclusion that sunscreen as a product category does not work. This was also a study from 2023, not a current ranking of every product on sale today.

What you do not need to buy or believe

• No special premium version just because it is called “natural”. Origin is no substitute for tested protection.
• No promise of “apply once, stay protected all day”. Swimming, sweating, towel-drying and friction do not disappear because of wording on a label.
• No automatic reliance on SPF in make-up. It can contribute if enough is applied, but the usual thin layer does not automatically provide the protection measured in an SPF test.
• No ever-more-expensive creams as a substitute for behaviour. Reducing intense exposure, clothing and a hat are valid forms of protection, not second-rate options.

Some more expensive products may feel nicer, suit a skin problem better or be easier to use. That may make the price worthwhile for someone; it is different from proven superior cancer prevention.[8][9]

7. Common influencer claims examined

Have a changing mole, a new growing skin lesion or a sore that does not heal assessed. Using sunscreen is no reason to ignore such changes.

8. Methods and sources

This is a focused review of the literature, not a full systematic review. The emphasis is on original clinical studies, a Cochrane review, WHO guidance, Dutch public information and data from regulatory authorities. Recent research on vitamin D was also sought. The sources were accessed on 20 September 2026; study years and limitations are stated alongside them.

How the evidence was weighed: a laboratory test can demonstrate UV filtering, but not cancer prevention directly. An observational association can be distorted by skin type and behaviour in the sun. Random allocation to groups provides stronger evidence of a causal effect, but small numbers of cancer cases still leave uncertainty. Moreover, multiple publications from the same study are not independent replications.

No products were tested or brands compared for this article. For some original papers, the full article was used; where only the authors' abstract was consulted, this is indicated in the source entry.

1. WHO — Ultraviolet radiation. Fact sheet on UV radiation, skin cancer, at-risk groups and protection. Supports the evidence that UV causes cancer and that shade and clothing take priority. Does not provide an individual percentage reduction in cancer from sunscreen.
2. WHO — Radiation: The ultraviolet (UV) index. Practical advice for different UV index levels. Protection from 3 upwards; under ordinary circumstances, additional protection is usually not needed at 0–2. Duration of exposure and exceptional situations remain relevant.
3. Green et al. — original Nambour trial (1999). Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin. The Lancet. Authors' abstract accessed via Europe PMC (PMID 10475183); counts of affected people additionally checked against Cochrane. The 39% reduction concerns SCC tumours per unit of observation time, not all skin cancer in individuals.
4. Van der Pols et al. — long-term SCC/BCC follow-up (2006). Prolonged Prevention of Squamous Cell Carcinoma of the Skin by Regular Sunscreen Use. Cancer Epidemiology, Biomarkers & Prevention. Full publication and table 3 checked. The longer SCC period used here is 1993–2004, not exclusively the years after the intervention ended. DOI: 10.1158/1055-9965.EPI-06-0352.
5. Green et al. — melanoma follow-up (2011). Reduced Melanoma After Regular Sunscreen Use: Randomized Trial Follow-Up. Journal of Clinical Oncology. Authors' abstract checked via Europe PMC (PMID 21135266) and the publisher; full text not freely available. Total: 11 versus 22; invasive: 3 versus 11. The overall result fell just short of statistical significance.
6. Sánchez et al. — Cochrane review (2016). Sun protection for preventing basal cell and squamous cell skin cancers. Full review, analyses 1.1 and 1.2, and study characteristics checked. Lower certainty for outcomes based on the number of affected individuals during the original trial. DOI: 10.1002/14651858.CD011161.pub2.
7. FDA — meaning and limitations of SPF. Sunscreen: How to Help Protect Your Skin from the Sun. SPF is not an allowable time in the sun or a cancer-risk percentage. For practical SPF advice, this article follows the Dutch KWF recommendation of at least SPF 30.
8. KWF — Dutch guidance on use. Tips for protecting yourself from the sun. All about sunscreen: amount, UVA filter, sprays and storage. Seek shade, cover up, apply sunscreen; at least SPF 30, enough product and reapplication. Public information, not a separate cancer trial.
9. Cancer Research UK — Sun safety. Sun protection, choosing a brand and the limitations of sunscreen. No brand recommendation; price or brand is no substitute for appropriate protection and application.
10. Waarzitwatin — Dutch government information on substances. Sunscreen: legal requirements, UVA symbol and possible hormonal effects. UV filters: types, allergy and the difference between skin application and inhalation. Describes assessment and authorised use; not proof that every possible long-term question has been resolved for every substance.
11. Matta et al. — absorption of UV filters (2020). Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients. JAMA. The authors' abstract was accessed via Europe PMC (PMID 31961417). Randomised study with 48 participants; measured absorption, not the development of cancer. DOI: 10.1001/jama.2019.20747.
12. FDA — benzene contamination and recalls. Frequently Asked Questions on Benzene Contamination in Drugs. Acknowledges real contamination problems, advises against using affected products and recommends continuing sun protection.
13. Tran et al. — Sun-D trial (2025). Effect of daily sunscreen application on vitamin D: findings from the open-label randomized controlled Sun-D Trial. British Journal of Dermatology. Authors' abstract accessed via Europe PMC (PMID 40927943), not the full article text. 639 people randomised, 628 in the main analysis; vitamin D level was the primary outcome. The deficiency analysis was exploratory.
14. Voedingscentrum — Vitamin D. Dutch dietary and supplementation advice by target group. Use this guidance for practical ways to meet vitamin D needs; a low blood level in an Australian study is not automatically a personal diagnosis.
15. NVWA — investigation of the SPF of 54 products (2023). Results of sunscreen SPF testing in 2023. Three products failed to meet the stated factor even in the standard test. There were also differences between testing methods. Not a current, comprehensive market ranking.
16. KNMI — UV index. The Dutch UV index scale and an explanation of UV exposure. The scale established in 2024 with the Dutch UV action platform recommends skin and eye protection from a UV index of 3 upwards.
17. Cancer Council Australia — application and choice. Sunscreen basics: seven teaspoons, reapplication and exceptions at low UV levels. Advice on how to choose, apply and store sunscreen. Practical advice from Australia, where sun exposure is often higher. Focuses on SPF 50/50+, lotions/creams and enough product; does not provide an individual cancer-prevention percentage.
18. Rueegg et al. — systematic review of bias (2019). Challenges in assessing the sunscreen-melanoma association. International Journal of Cancer. Explains why observational associations can be distorted by skin type and sun exposure. Not an independent replication of the Nambour trial. DOI: 10.1002/ijc.31997.
19. Waarzitwatin — specific substances and routes of exposure. Homosalate. Oxybenzone. Octocrylene. Titanium dioxide, nano, inhalation and ingestion. Supports the distinction between legal restrictions, laboratory signals, allergy and demonstrated risks at a particular exposure. Not used as a guarantee of zero risk.